Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 8
Submit an article Journal homepage
4,517
Views
31
CrossRef citations to date
0
Altmetric
Diabetes

Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin

Priscilla HollanderBaylor Endocrine Center, Dallas, TX, USA;
,
Julie HillMerck & Co. Inc., Kenilworth, NJ, USA;
,
Jeremy JohnsonMerck & Co. Inc., Kenilworth, NJ, USA;
,
Zhi Wei JiangMSD R&D (China) Co. Ltd, Beijing, China;
,
Gregory GolmMerck & Co. Inc., Kenilworth, NJ, USA;
,
Susan HuyckMerck & Co. Inc., Kenilworth, NJ, USA;
,
Steven G. TerraPfizer Inc., Andover, MA, USA;
,
James P. MancusoPfizer Inc., Groton, CT, USA;
,
Samuel S. EngelMerck & Co. Inc., Kenilworth, NJ, USA;
,
Brett Lauringformerly of Merck & Co. Inc., Kenilworth, NJ, USA; ;Currently at Takeda Pharmaceuticals, Cambridge, MA, USA
&
Jie LiuMerck & Co. Inc., Kenilworth, NJ, USA; Correspondence[email protected]
 show all
Pages 1335-1343 | Received 22 Oct 2018, Accepted 08 Feb 2019, Published online: 25 Mar 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.